Therapeutic Targeting of the TGFβ Pathway Augments CAR T cell Efficacy in Glioblastoma
Chimeric Antigen Receptor (CAR) T therapy represents a promising approach to improve outcomes for patients with high-grade gliomas (HGG). Recently, we repo
Chimeric Antigen Receptor (CAR) T therapy represents a promising approach to improve outcomes for patients with high-grade gliomas (HGG). Recently, we repo